BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23458598)

  • 1. Suppressing commercial speech is not in the best interests of physicians and patients.
    Chressanthis G; Khedkar P; Jain N; Poddar P; Seiders M
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):219-20. PubMed ID: 23458598
    [No Abstract]   [Full Text] [Related]  

  • 2. Should physicians rely on pharmaceutical detailing for their education?
    van Schalkwyk JM; Turner MJ
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 4. Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.
    Chressanthis GA; Khedkar P; Jain N; Poddar P; Seiders MG
    J Clin Hypertens (Greenwich); 2012 Jul; 14(7):435-46. PubMed ID: 22747616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doctors behaving badly?
    Tattersall MH; Kerridge IH
    Med J Aust; 2006 Sep; 185(6):299-300. PubMed ID: 16999666
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict of interest: the elephant in your practice.
    Kaliski S
    Afr J Psychiatry (Johannesbg); 2013 May; 16(3):161, 163, 165. PubMed ID: 23739815
    [No Abstract]   [Full Text] [Related]  

  • 7. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
    Brown JL
    Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
    [No Abstract]   [Full Text] [Related]  

  • 8. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conflicts of interest: an academic proposal].
    Lama A
    Rev Med Chil; 2006 Jun; 134(6):800. PubMed ID: 17130959
    [No Abstract]   [Full Text] [Related]  

  • 10. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 12. The baby with the bathwater.
    Buyske J
    Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conflicts of interest, an insidious blight on medicine].
    Altisent R
    Aten Primaria; 2019 Oct; 51(8):469-470. PubMed ID: 31202475
    [No Abstract]   [Full Text] [Related]  

  • 14. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 15. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
    Ichikawa I; Clayton EW
    Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixing Dinner and Drugs-Is It Ethically Contraindicated?
    Essi DF
    AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conflicts of interest in the medical profession].
    Altisent R; Delgado-Marroquín MT; Astier-Peña MP
    Aten Primaria; 2019 Oct; 51(8):506-511. PubMed ID: 31248656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunshine Has Darkened my Worldview.
    Alward WL
    Am J Ophthalmol; 2017 Mar; 175():xii-xiii. PubMed ID: 28088286
    [No Abstract]   [Full Text] [Related]  

  • 19. New Swiss guidelines aim to curb big pharma's influence.
    Hyde R
    Lancet; 2013 Feb; 381(9865):441-2. PubMed ID: 23405415
    [No Abstract]   [Full Text] [Related]  

  • 20. Docking the tail that wags the dog: banning drug reps from academic medical facilities.
    Millard WB
    Ann Emerg Med; 2007 Jun; 49(6):785-91. PubMed ID: 17536244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.